Leukemia, Myeloid, Accelerated Phase
Also known as: Accelerated phase chronic myologenic leukaemia / Chronic Myelogenous Leukemia, Accelerated Phase / Chronic Myeloid Leukemia - Accelerated Phase / Accelerated phase chronic myologenic leukemia / Accelerated Phase Chronic Myelogenous Leukemia / Accelerated Phase Chronic Myelogenous Leukemia (CML) / Accelerated Phase Chronic Myeloid Leukemia / Leukemia, Myeloid, Accelerated-Phase / Accelerated phase chronic myeloid leukemia (disorder) / Chronic myeloid leukaemia / Leukemia myelocytic chronic / Leukaemia myelocytic chronic / Chronic granulocytic leukaemia / Chronic myelogenous leukaemia / Myeloid leukemia, chronic / Chronic myelogenous leukemia / Chronic granulocytic leukemia / Myeloid leukaemia, chronic / CML / Chronic myelocytic leukaemia / Chronic myelocytic leukemia / Chronic myeloid leukemia / Leukaemias chronic myeloid / Chronic myeloid leukemia, BCR/ABL-positive / Chronic myeloid leukemia (disorder) / Chronic myeloid leukemia (morphologic abnormality) / Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Drug | Drug Name | Drug Description |
---|---|---|
DB06616 | Bosutinib | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. |
DB01254 | Dasatinib | A tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia. |
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
DB04868 | Nilotinib | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. |
DB08901 | Ponatinib | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). |